What are the Mechanisms of Resistance to PARP Inhibitors?
Despite initial success, some cancers develop resistance to PARP inhibitors. Mechanisms of resistance include restoration of homologous recombination repair, increased drug efflux, and mutations in the PARP enzymes themselves. Understanding these mechanisms is crucial for developing next-generation inhibitors and combination therapies to overcome resistance.
